
AgomAb
Developer of fibrotic disease treatments intended to preserve and restore organ function in fibrotic. The company specializes in growth factor biology and offers treatment that simulates molecular and...
Valuation
$415.6M
Latest known
Share Price
N/A
Total Raised
$334M
Last Round
N/A